Capital Management Corp Anika Therapeutics, Inc. Transaction History

Capital Management Corp

$526 Million
Q2 2025

A detailed history of Capital Management Corp transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Capital Management Corp holds 408,845 shares of ANIK stock, worth $3.57 Million. This represents 0.82% of its overall portfolio holdings.

Number of Shares

408,845

Previous 329,660 24.02%

Holding current value

$3.57 Million

Previous $4.95 Million 12.7%

% of portfolio

0.82%

Previous 1.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 28, 2025	BUY	$10.58 - $15.05 $837,777 - $1.19 Million	79,185 Added 24.02%	408,845 $4.33 Million
Q1 2025 May 05, 2025	BUY	$15.03 - $17.97 $61,848 - $73,946	4,115 Added 1.26%	329,660 $4.95 Million
Q4 2024 Feb 07, 2025	BUY	$16.04 - $25.53 $564,527 - $898,528	35,195 Added 12.12%	325,545 $5.36 Million
Q3 2024 Oct 30, 2024	SELL	$24.25 - $28.75 $928,047 - $1.1 Million	-38,270 Reduced 11.65%	290,350 $7.17 Million
Q2 2024 Jul 25, 2024	SELL	$24.57 - $28.47 $869,900 - $1.01 Million	-35,405 Reduced 9.73%	328,620 $8.32 Million
Q1 2024 May 10, 2024	BUY	$21.95 - $26.42 $186,377 - $224,332	8,491 Added 2.39%	364,025 $9.25 Million
Q4 2023 Feb 01, 2024	BUY	$18.47 - $23.3 $5.01 Million - $6.32 Million	271,309 Added 322.12%	355,534 $8.06 Million
Q3 2023 Oct 30, 2023	BUY	$16.98 - $26.1 $1.43 Million - $2.2 Million	84,225 New	84,225 $1.57 Million
Q3 2022 Oct 31, 2022	SELL	$21.74 - $24.68 $3.76 Million - $4.26 Million	-172,740 Reduced 62.78%	102,390 $2.44 Million
Q2 2022 Jul 25, 2022	BUY	$20.4 - $25.53 $1.49 Million - $1.86 Million	72,872 Added 36.03%	275,130 $6.14 Million
Q1 2022 May 03, 2022	BUY	$24.7 - $36.54 $1.71 Million - $2.54 Million	69,408 Added 52.25%	202,258 $5.08 Million
Q4 2021 Feb 08, 2022	BUY	$35.83 - $45.03 $514,518 - $646,630	14,360 Added 12.12%	132,850 $4.76 Million
Q3 2021 Oct 25, 2021	BUY	$38.75 - $44.47 $743,418 - $853,156	19,185 Added 19.32%	118,490 $5.04 Million
Q2 2021 Jul 30, 2021	SELL	$39.42 - $48.08 $1.81 Million - $2.21 Million	-46,005 Reduced 31.66%	99,305 $4.3 Million
Q1 2021 Apr 26, 2021	BUY	$32.49 - $45.96 $1.7 Million - $2.4 Million	52,275 Added 56.19%	145,310 $5.93 Million
Q4 2020 Feb 04, 2021	SELL	$32.59 - $45.26 $58,499 - $81,241	-1,795 Reduced 1.89%	93,035 $4.21 Million
Q3 2020 Oct 27, 2020	SELL	$32.56 - $38.57 $2.75 Million - $3.25 Million	-84,321 Reduced 47.07%	94,830 $3.36 Million
Q2 2020 Jul 29, 2020	BUY	$27.83 - $37.73 $2.4 Million - $3.25 Million	86,246 Added 92.83%	179,151 $6.76 Million
Q1 2020 May 05, 2020	BUY	$22.38 - $54.06 $966,659 - $2.34 Million	43,193 Added 86.89%	92,905 $2.69 Million
Q4 2019 Feb 03, 2020	BUY	$51.85 - $73.36 $45,109 - $63,823	870 Added 1.78%	49,712 $2.58 Million
Q3 2019 Oct 30, 2019	SELL	$40.05 - $57.47 $906,291 - $1.3 Million	-22,629 Reduced 31.66%	48,842 $2.68 Million
Q2 2019 Jul 31, 2019	SELL	$30.3 - $41.14 $1.23 Million - $1.67 Million	-40,525 Reduced 36.18%	71,471 $2.9 Million
Q1 2019 Apr 25, 2019	BUY	$29.37 - $40.49 $298,898 - $412,066	10,177 Added 10.0%	111,996 $3.39 Million
Q4 2018 Jan 29, 2019	BUY	$30.16 - $43.0 $657,307 - $937,142	21,794 Added 27.23%	101,819 $3.42 Million
Q3 2018 Oct 31, 2018	SELL	$32.83 - $42.51 $1.6 Million - $2.07 Million	-48,712 Reduced 37.84%	80,025 $3.38 Million
Q2 2018 Jul 27, 2018	BUY	$28.77 - $48.27 $1.68 Million - $2.82 Million	58,319 Added 82.82%	128,737 $4.12 Million
Q1 2018 Apr 25, 2018	BUY	$49.22 - $68.43 $459,370 - $638,657	9,333 Added 15.28%	70,418 $3.5 Million
Q4 2017 Jan 30, 2018	SELL	$52.14 - $59.94 $15,120 - $17,382	-290 Reduced 0.47%	61,085 $3.29 Million
Q3 2017 Nov 01, 2017	BUY	$51.16 - $58.21 $3.14 Million - $3.57 Million	61,375	61,375 $3.56 Million

Others Institutions Holding ANIK

# of Institutions

105

Shares Held

11.4M

Call Options Held

Put Options Held

View Full List

About Anika Therapeutics, Inc.

Ticker ANIK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,599,900
Market Cap $127M
Description
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...

More about ANIK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Capital Management Corp with notifications on news.

Account

Capital Management Corp Anika Therapeutics, Inc. Transaction History